Page last updated: 2024-08-22

palladium and olomoucine

palladium has been researched along with olomoucine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dolezal, K; Malon, M; Marek, J; Strnad, M; Trávnícek, Z; Zatloukal, M	1

Other Studies

1 other study(ies) available for palladium and olomoucine

Article	Year
Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine]. Journal of inorganic biochemistry, 2003, Apr-01, Volume: 94, Issue:4 Topics: Antineoplastic Agents; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kinetin; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organometallic Compounds; Organoplatinum Compounds; Palladium; Platinum; Purines; Structure-Activity Relationship; Tumor Cells, Cultured	2003

Article

Year

Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].

Journal of inorganic biochemistry, 2003, Apr-01, Volume: 94, Issue:4

Topics: Antineoplastic Agents; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kinetin; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organometallic Compounds; Organoplatinum Compounds; Palladium; Platinum; Purines; Structure-Activity Relationship; Tumor Cells, Cultured

2003